Artal Group’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-350,000
Closed -$8.14M 101
2024
Q2
$8.14M Buy
+350,000
New +$8.14M 0.21% 44